Related Professionals: Lisa A. Chiarini Richard J. Tannenbaum Douglas J. Wood

February 16, 2016 – Reed Smith LLP today announced the addition of Lisa Chiarini as a partner in the firm’s Intellectual Property, Information & Innovation (IPII) Group in New York. Chiarini was most recently a partner at Fish & Richardson. The addition of Chiarini follows closely on that of Rich Tannenbaum, who joined the firm recently from GE Capital. New York remains one of Reed Smith’s fastest-growing offices, adding 38 lawyers over the past year.

“Along with our nationally recognized IP practice, we have a leading life science and health industry practice with many Big Pharma clients, so Lisa’s experience with litigating disputes in district court, the International Trade Commission, and ICC arbitration tribunals in this industry will be of enormous benefit to our clients,” said James Hultquist, co-practice group leader for Reed Smith's IPII Group. “Our IP practice is busy and growing, and we will continue to add leading talent so that we can better serve our clients’ IP needs.”

Chiarini focuses her practice on IP litigation and product development counseling services in the pharmaceutical, chemical, and medical device industries. She has handled IP disputes at the International Trade Commission (ITC), in federal district court, and before the International Chamber of Commerce (ICC) International Court of Arbitration. Significant matters she has handled include representing a branded pharmaceutical company in one of the first actions at the ITC seeking an order to exclude generic entry of an active ingredient allegedly made by an infringing process, and being a member of the trial team in the first-ever patent litigation involving nanomedicine in the U.S. District Court of Delaware. Aside from patent litigation, Chiarini’s practice includes patent prosecution and counseling in the life sciences and health industry.

She received her J.D., cum laude, from Brooklyn Law School; her M.S., with honors, from Hofstra University; and her B.S. from St. Joseph’s College.

“Lisa is the second partner to join us in New York in the last month,” said Douglas Wood, office managing partner of Reed Smith’s New York office. “We are focused on building a robust office here in New York that offers clients a comprehensive resource for their legal needs. Lisa is a great addition to our team here.”

Reed Smith's Intellectual Property, Information & Innovation Group comprises more than 100 attorneys worldwide and handles a range of IP matters for clients, including those involving patents, copyrights, trademarks, unfair competition and trade secrets, transactions, and domain name disputes. Our attorneys have strong technical credentials, IP litigation skills, and jury trial experience, as well as extensive experience in the industries in which our clients operate.

Reed Smith’s Life Sciences Health Industry (LSHI) Group is dedicated to addressing and solving the problems of businesses operating in the pharmaceutical, medical device, biotechnology, life sciences and health care sectors. From product development and management requirements to regulatory demands and litigation risks, the group represents virtually every type of entity operating in or related to the life sciences and health care industry, including all types of health care providers, such as hospitals and health systems, long-term care facilities, hospices, home health and rehabilitation providers, physicians, and others; and many of the world’s largest pharmaceutical and medical device manufacturers.

About Reed Smith

Reed Smith is a global relationship law firm with more than 1,800 lawyers in 26 offices throughout the United States, Europe, Asia and the Middle East. Founded in 1877, the firm represents leading international businesses, from Fortune 100 corporations to mid-market and emerging enterprises. Its lawyers provide litigation and other dispute-resolution services in multi-jurisdictional and other high-stakes matters; deliver regulatory counsel; and execute the full range of strategic domestic and cross-border transactions. Reed Smith is a preeminent advisor to industries including financial services, life sciences, health care, advertising, entertainment and media, shipping and transport, energy and natural resources, real estate, manufacturing, technology, and education. For more information, visit

U.S.: Century City, Chicago, Houston, Los Angeles, New York, Northern Virginia, Philadelphia, Pittsburgh, Princeton, Richmond, San Francisco, Silicon Valley, Washington, D.C., Wilmington

Europe: Athens, Frankfurt, London, Munich, Paris

Middle East: Abu Dhabi, Dubai

Asia: Beijing, Hong Kong, Kazakhstan, Shanghai, Singapore